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Growth kinetica b s t r a c t
Dengue fever is currently the most important mosquito-borne viral disease in Indonesia. In South
Sulawesi province, most regions report dengue cases including the capital city, Makassar. Currently, no
information is available on the serotypes and genotypes of the viruses circulating in the area. To under-
stand the dynamic of dengue disease in Makassar, we carried out dengue fever surveillance study during
2007–2010. A total of 455 patients were recruited, in which antigen and serological detection revealed
the conﬁrmed dengue cases in 43.3% of patients. Molecular detection conﬁrmed the dengue cases in
27.7% of patients, demonstrating that dengue places a signiﬁcant disease burden on the community.
Serotyping revealed that dengue virus serotype 1 (DENV-1) was the most predominant serotype,
followed by DENV-2, -3, and -4. To determine the molecular evolution of the viruses, we conducted
whole-genome sequencing of 80 isolates. Phylogenetic analysis grouped DENV-2, -3 and -4 to the
Cosmopolitan genotype, Genotype I and Genotype II, respectively. Intriguingly, each serotype paints a dif-
ferent picture of evolution and transmission. DENV-1 appears to be undergoing a clade replacement with
Genotype IV being supplanted by Genotype I. The Cosmopolitan DENV-2 isolates were found to be
regionally endemic and is frequently being exchanged between countries in the region. By contrast,
DENV-3 and DENV-4 isolates were related to strains with a long history in Indonesia although the
DENV-3 strains appear to have been following a distinct evolutionary path since approximately 1998.
To assess whether the various DENV serotypes/genotypes possess different growth characteristics, we
performed growth kinetic assays on selected viruses. We observed the relatively higher rate of replication
for DENV-1 and -2 compared to DENV-3 and -4. Within the DENV-1, viruses from Genotype I grow faster
than that of Genotype IV. This higher replication rate may underlie their ability to replace the circulation
of Genotype IV in the community.
 2015 The Authors. Published by Elsevier B.V. This is an open access articleunder the CCBY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Dengue fever is an acute febrile disease caused by dengue virus
(DENV) infection, transmitted through the mosquito vector Aedes
aegypti. The symptoms of the DENV infection vary from classic
Dengue Fever (DF) to severe forms such as Dengue Hemorrhagic
Fever (DHF) and the potentially fatal Dengue Shock Syndrome
(DSS). DENV is an enveloped ﬂavivirus with a 10.7 kb single-
stranded positive-sense RNA genome. There are four antigenically
distinct serotypes of the virus (DENV-1, -2, -3, and -4), with around
65% genome similarity, circulating throughout the tropical and
sub-tropical regions of the world (Gubler, 1998; Guzman et al.,
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identical.
Indonesia is a dengue endemic country that experiences peri-
odic major outbreaks of the disease, such as those in 1998
(Corwin et al., 2001) and 2004 (Suwandono et al., 2006). In addi-
tion, annual and sporadic occurrences regularly afﬂict all the 33
provinces of the vast Indonesian archipelago (Sumarmo, 1987).
While there have been studies describing the molecular genetics
of dengue viruses isolated from Western part of the Indonesian
archipelago (Sumatra and Java Islands) (Ong et al., 2008;
Raekiansyah et al., 2005), no data is available for other major
islands in the Eastern part of Indonesia, such as Sulawesi island.
Data from the South Sulawesi provincial health authority (www.
dinkes-sulsel.go.id) described the increasing number of dengue
incidents in South Sulawesi province in 2007, in which 5333
patients were admitted to hospitals. In the capital city, Makassar,
the dengue incidence was recorded at 425 cases with 5 fatalities.
Dengue diagnosis in Makassar is commonly performed based on
clinical symptoms only as the lack of resources and relatively high
cost of laboratory tests prohibit serological conﬁrmation. Because
of this, the reported incidence may not represent the true disease
burden.
Comparative analysis of dengue genomes has been used widely
to study the genetic diversity of the dengue viruses (Holmes and
Burch, 2000; Holmes and Twiddy, 2003) and previous studies have
also suggested a correlation between viral pathogenicity with its
genetic structures in which mutations in viral genome enhances
the viral pathogenesis (Leitmeyer et al., 1999; Pandey and
Igarashi, 2000). To understand the dengue disease dynamic in
Makassar city, Indonesia, we studied the molecular evolution of
circulating dengue viruses by analyzing the genomes of the viruses
isolated in the area. We observed the diversity of serotypes and
genotypes of dengue viruses and hypothesized that spatial isola-
tion may contribute to the diversity of dengue viruses circulating
in Makassar, South Sulawesi, Indonesia. To complement the viral
genetic data, we performed viral growth characterization of vari-
ous serotypes/genotypes. This study provides information in the
genetic and biological characteristics of the diverse dengue virus
strains circulating in Makassar, Indonesia.2. Materials and methods
2.1. Study site and patient recruitment
We conducted surveillance of febrile patients in Makassar, the
capital city of South Sulawesi province, Indonesia. The city resides
in an area of about 175.77 km2, inhabited by about 1.3 million peo-
ple (http://makassarkota.go.id). Makassar city is located about
1400 km east of the Indonesian capital of Jakarta. Dengue-sus-
pected febrile patients admitted to Dr. Wahidin Sudirohusodo,
Labuang Baji and Daya Hospitals and primary health care centers
in Makassar were enrolled in the study upon obtaining written
consent. For the minors/children participants, written consents
were obtained from parents/legal guardians. We obtained ethical
clearances for this study from the Hasanuddin University Medical
Research Ethics Committee and the Eijkman Institute Research
Ethics Committee. All patients aged between 5 and 100 years old
with fever >38.0 C for less than 72 h and without concurrent signs
of upper respiratory infection or obvious alternate diagnoses to
dengue were invited to participate in the study. In total, we
obtained 455 serum samples during the patient recruitment period
(May 2007–August 2010).
Initial screening on dengue-suspected patients was determined
serologically using anti-dengue IgM and IgG (Panbio Dengue Duo
IgM/IgG enzyme-linked immunosorbent assay (ELISA) kit (Panbio,Brisbane, Australia)). Dengue conﬁrmation by detection of NS1
antigen was done using NS1 rapid test kit (Standard Diagnostics,
Korea). Primary versus secondary dengue infectionwas determined
using the ELISA results according to manufacturer’s protocol.
Brieﬂy, the positive IgM (>11 Panbio Units) and negative IgG
(<22 Panbio Units) indicated primary infection while positive IgG
(>22 Panbio Units), which may be accompanied by elevated IgM
levels, indicated secondary infection. The presence of viral RNA in
NS1-positive samples was further conﬁrmed by reverse transcrip-
tion-polymerase chain reaction (RT-PCR) using method described
by Lanciotti et al. (1992), with modiﬁcation according to Harris
et al. (1998). All dengue positive cases were categorized either den-
gue fever (DF) or Dengue Hemorrhagic Fever (DHF) according to
criteria described by the WHO (WHO, 1997).
2.2. Virus propagation, cell lines, RNA extraction and serotyping
Viruses were isolated from RT-PCR positive samples, either
directly from patients’ sera or after one passage (or maximum of
two passages for low titer isolates) of virus propagation in C6/36
Aedes albopictus gut cell lines. Baby hamster kidney (BHK-21) and
C6/36 cell lines were maintained in RPMI 1640 medium (Gibco,
Carlsbad, CA). African green monkey kidney (Vero76) cell line
was maintained in Minimum Essential Medium (MEM) with
Earle’s salts (Gibco). Media were supplemented with 10% heat-
inactivated fetal bovine serum (FBS; Gibco), 2 mM glutamine,
100 U/ml penicillin, and 100 lg/ml streptomycin (Gibco) for cell
maintenance. BHK-21 and Vero76 cell culture was maintained in
37 C incubator (ESCO) supplemented with 5% CO2. C6/36 cell cul-
ture was maintained in 28 C incubator. Virus stock titer was mea-
sured using modiﬁed standard plaque assay method (Fink et al.,
2007) and recorded as plaque forming unit (PFU) equivalent/ml.
QIAamp Viral RNA Mini Kits (Qiagen, Hilden, Germany) were
used to extract viral genomic RNAs from patients’ sera or cell cul-
ture supernatant according to the manufacturer’s instructions.
Dengue viral RNA was reverse-transcribed into cDNA using
Superscript III reverse transcriptase (RT) (Invitrogen, Carlsbad,
CA) and DENV-speciﬁc primers (Lanciotti et al., 1992).
Subsequently, cDNA was ampliﬁed using Taq DNA polymerase
(Roche, Mannheim, Germany). The four dengue serotypes were
distinguished by PCR product size.
2.3. Whole genome sequencing
Five overlapping PCR fragments covering the whole dengue
genome were ampliﬁed using methods described previously (Ong
et al., 2008; Schreiber et al., 2009) with slight modiﬁcations.
Brieﬂy, genomic RNAs were reverse-transcribed into cDNA using
primers speciﬁc for each serotype. The primers used for DENV-4
sequencing were as listed in Supplementary Table 1. Fragment
ampliﬁcation was performed using high-ﬁdelity Pfu Turbo DNA
polymerase (Stratagene, La Jolla, CA). Typical PCR conditions were
as follows: templates were denatured for 2 min at 95 C, followed
by 45 cycles of 30 s denaturation at 95 C, 1 min annealing at 55 C,
and 4.5 min extension at 72 C. Templates were allowed a 10 min
ﬁnal extension step at 72 C followed by storage at 4 C. PCR prod-
ucts were puriﬁed from 0.8% agarose gel using QIAquick gel extrac-
tion kit (Qiagen) and used as template for cycle sequencing. DNA
sequencing was performed using BigDye Dideoxy Terminator
sequencing kits v3.1 (Applied Biosystems, Foster City, CA) using
the method described in the kit. In addition to the sequencing
and ampliﬁcation primers previously described by Ong et al.
(2008), a new set of primers for DENV-4 were used. Primer
sequences and predicted genome binding positions of RT-PCR pri-
mers for DENV-4 are listed in Supplementary Tables 2 and 3,
respectively. Puriﬁed sequencing reactions were then run on
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Institute sequencing facility. Contig assembly was performed using
SeqScape 2.5 (Applied Biosystem) with additional manual adjust-
ment performed when manual inspection of the assembly showed
some discrepancies. All genome sequences obtained in this study
have been deposited in GenBank (Table 1).Table 1
Characteristics of the Makassar DENV samples with whole-genomes sequenced.
No Sample ID Accession no. Sex Is
1. D1/ID/MKS-0055/2007 KC762649 F Ju
2. D1/ID/MKS-0056/2007 KC762625 F Ju
3. D1/ID/MKS-0077/2007 KC762654 F Ju
4. D1/ID/MKS-0080/2007 KC762636 F Ju
5. D1/ID/MKS-0088/2007 KC762635 M O
6. D1/ID/MKS-0109/2007 KC762650 F Ju
7. D1/ID/MKS-0206/2007 KC762623 F Ju
8. D1/ID/MKS-0248/2007 KC762632 M A
9. D1/ID/MKS-0344/2007 KC762646 M A
10. D1/ID/MKS-0352/2007 KC762637 F D
11. D1/ID/MKS-0390/2007 KC762620 F D
12. D1/ID/MKS-0395/2008 KC762631 M F
13. D1/ID/MKS-0397/2008 KC762621 F F
14. D1/ID/MKS-0398/2008 KC762643 M F
15. D1/ID/MKS-0483/2007 KC762651 M D
16. D1/ID/MKS-0486/2008 KC762653 M F
17. D1/ID/MKS-2029/2008 KC762640 M M
18. D1/ID/MKS-2040/2008 KC762645 F F
19. D1/ID/MKS-2058/2008 KC762628 F F
20. D1/ID/MKS-2082/2008 KC762624 M F
21. D1/ID/MKS-2094/2008 KC762644 M F
22. D1/ID/MKS-2097/2008 KC762630 F F
23. D1/ID/MKS-2138/2008 KC762626 F F
24. D1/ID/MKS-2147/2008 KC762641 F F
25. D1/ID/MKS-2194/2008 KC762648 M A
26. D1/ID/MKS-2200/2008 KC762622 M A
27. D1/ID/MKS-2201/2008 KC762634 F A
28. D1/ID/MKS-2216/2008 KC762633 M A
29. D1/ID/MKS-1001/2008 KC762652 F A
30. D1/ID/MKS-2004/2008 KC762638 F F
31. D1/ID/MKS-IF039/2008 KC762629 F M
32. D1/ID/MKS-IF062/2008 KC762627 F A
33. D1/ID/MKS-WS72/2010 KC762647 M M
34. D1/ID/MKS-WS81/2010 KC762639 M A
35. D1/ID/MKS-WS88/2010 KC762642 M Ju
36. D2/ID/MKS-0068/2007 KC762665 M Ju
37. D2/ID/MKS-0071/2007 KC762669 M Ju
38. D2/ID/MKS-0082/2007 KC762658 M A
39. D2/ID/MKS-0084/2007 KC762660 M N
40. D2/ID/MKS-0091/2007 KC762670 M D
41. D2/ID/MKS-0099/2007 KC762676 F Ju
42. D2/ID/MKS-0297/2007 KC762662 M N
43. D2/ID/MKS-0412/2007 KC762661 F S
44. D2/ID/MKS-0417/2007 KC762655 F S
45. D2/ID/MKS-0502/2007 KC762656 M D
46. D2/ID/MKS-2032/2008 KC762675 M M
47. D2/ID/MKS-2108/2008 KC762671 F F
48. D2/ID/MKS-2145/2008 KC762664 F M
49. D2/ID/MKS-2167/2008 KC762674 F M
50. D2/ID/MKS-2198/2008 KC762672 F A
51. D2/ID/MKS-2204/2008 KC762667 M A
52. D2/ID/MKS-2210/2008 KC762659 F A
53. D2/ID/MKS-2234/2008 KC762657 M A
54. D2/ID/MKS-3007/2008 KC762666 F F
55. D2/ID/MKS-2024/2008 KC762663 M F
56. D2/ID/MKS-2018/2008 KC762673 M M
57. D2/ID/MKS-IF011/2008 KC762677 M F
58. D2/ID/MKS-IF014/2008 KC762668 F M
59. D2/ID/MKS-WS73/2010 KC762678 M M
60. D2/ID/MKS-WS79a/2010 KC762679 F M
61. D2/ID/MKS-WS80/2010 KC762680 M A
62. D3/ID/MKS-0057/2007 KC762681 F Ju
63. D3/ID/MKS-0076/2007 KC762682 F Ju2.4. Sequence, phylogenetic and evolutionary analysis
We downloaded all DNA sequences for the DENV-1, -2, -3 and
-4 from NCBI GenBank database as of 13 April 2012. All sequences
from respected dengue serotype which had 90% identities with any
of the samples for 90% coverage of their sequences were searchedolation time Serotype Genotype Infection status
l 2007 DENV-1 I Primary
n 2007 DENV-1 I Primary
l 2007 DENV-1 I Primary
l 2007 DENV-1 I Primary
ct 2007 DENV-1 I Primary
n 2007 DENV-1 I Primary
l 2007 DENV-1 I Primary
ug 2007 DENV-1 I Primary
ug 2007 DENV-1 I Primary
ec 2007 DENV-1 I Primary
ec 2007 DENV-1 IV Primary
eb 2008 DENV-1 I Primary
eb 2008 DENV-1 I Primary
eb 2008 DENV-1 I Primary
ec 2007 DENV-1 IV Primary
eb 2008 DENV-1 IV Primary
ar 2008 DENV-1 IV Primary
eb 2008 DENV-1 I Primary
eb 2008 DENV-1 IV Primary
eb 2008 DENV-1 I Primary
eb 2008 DENV-1 I Primary
eb 2008 DENV-1 IV Primary
eb 2008 DENV-1 I Primary
eb 2008 DENV-1 I Primary
pr 2008 DENV-1 I Primary
pr 2008 DENV-1 I Primary
pr 2008 DENV-1 I Primary
pr 2008 DENV-1 I Primary
pr 2008 DENV-1 I Primary
eb 2008 DENV-1 I Primary
ar 2008 DENV-1 I Primary
pr 2008 DENV-1 I Secondary
ar 2010 DENV-1 I Primary
pr 2010 DENV-1 I Primary
l 2010 DENV-1 I Primary
l 2007 DENV-2 Cosmopolitan Primary
l 2007 DENV-2 Cosmopolitan Primary
ug 2007 DENV-2 Cosmopolitan Secondary
ov 2007 DENV-2 Cosmopolitan Primary
ec 2007 DENV-2 Cosmopolitan Primary
l 2007 DENV-2 Cosmopolitan Primary
ov 2007 DENV-2 Cosmopolitan Primary
ep 2007 DENV-2 Cosmopolitan Secondary
ep 2007 DENV-2 Cosmopolitan Primary
ec 2007 DENV-2 Cosmopolitan Primary
ar 2008 DENV-2 Cosmopolitan Primary
eb 2008 DENV-2 Cosmopolitan Primary
ar 2008 DENV-2 Cosmopolitan Primary
ar 2008 DENV-2 Cosmopolitan Primary
pr 2008 DENV-2 Cosmopolitan Primary
pr 2008 DENV-2 Cosmopolitan Primary
pr 2008 DENV-2 Cosmopolitan Secondary
pr 2008 DENV-2 Cosmopolitan Primary
eb 2008 DENV-2 Cosmopolitan Primary
eb 2008 DENV-2 Cosmopolitan Primary
ar 2008 DENV-2 Cosmopolitan Primary
eb 2008 DENV-2 Cosmopolitan Primary
ar 2008 DENV-2 Cosmopolitan Primary
ar 2010 DENV-2 Cosmopolitan Primary
ar 2010 DENV-2 Cosmopolitan Primary
pr 2010 DENV-2 Cosmopolitan Primary
n 2007 DENV-3 I Primary
l 2007 DENV-3 I Primary
(continued on next page)
Table 1 (continued)
No Sample ID Accession no. Sex Isolation time Serotype Genotype Infection status
64. D3/ID/MKS-0079/2007 KC762683 F Jul 2007 DENV-3 I Primary
65. D3/ID/MKS-0098/2007 KC762684 M Jul 2007 DENV-3 I Secondary
66. D3/ID/MKS-0172/2007 KC762686 M Jul 2007 DENV-3 I Secondary
67. D3/ID/MKS-0388/2008 KC762685 F Feb 2008 DENV-3 I Primary
68. D3/ID/MKS-0396/2008 KC762687 M Feb 2008 DENV-3 I Primary
69. D3/ID/MKS-2065/2008 KC762689 F Feb 2008 DENV-3 I Primary
70. D3/ID/MKS-3000/2008 KC762690 M Aug 2008 DENV-3 I Primary
71. D3/ID/MKS-2006/2008 KC762688 M Apr 2008 DENV-3 I Primary
72. D3/ID/MKS-IF058/2008 KC762691 M Apr 2008 DENV-3 I Primary
73. D3/ID/MKS-WS78/2010 KC762692 F Mar 2010 DENV-3 I Secondary
74. D3/ID/MKS-WS79b/2010 KC762693 F Mar 2010 DENV-3 I Primary
75. D4/ID/MKS-0033/2007 KC762694 M May 2007 DENV-4 II Primary
76. D4/ID/MKS-0070/2007 KC762695 M Jul 2007 DENV-4 II Primary
77. D4/ID/MKS-0252/2008 KC762696 M Aug 2007 DENV-4 II Primary
78. D4/ID/MKS-0706/2008 KC762697 - Feb 2008 DENV-4 II Primary
79. D4/ID/MKS-2139/2008 KC762699 M Mar 2008 DENV-4 II Primary
80. D4/ID/MKS-2007/2008 KC762698 M Apr 2008 DENV-4 II Primary
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with the samples were then aligned using MUSCLE (Edgar, 2004).
The alignments were trimmed for their 50-UTR and 30-UTR leaving
only the coding regions. A maximum likelihood phylogenetic tree
using GTR substitution model and gamma distribution for varying
rate for each serotype was constructed by FastTree (Price et al.,
2010). The phylogenetic trees were used to collect 60 most-closely
related published sequences from each of the samples as reference
sequences by calculating the patristic distance as implemented in
DendroPy (Sukumaran and Holder, 2010).
MUSCLE (Edgar, 2004) was utilized to create the multiple
sequence alignment of each dengue virus serotype for the
untrimmed sample and the collected reference sequences. We par-
titioned the alignments into 5-UTR, coding and 3-UTR regions
accordingly. We determined the best model of evolution for each
region by sampling across substitution model space in Bayesian
MCMC analysis as implemented in MrBayes (Huelsenbeck and
Ronquist, 2001). For all serotypes, we selected the GTR with invari-
able sites and 4 classes of gamma-distribution (GTR + I +C4) with
codon model and TrN model with invariable sites and 4 classes
of gamma-distribution (TrN + I +C4) for the coding region and 30-
UTR, respectively, as these were the models implemented in
BEAST that were close enough to the models suggested by
MrBayes. Bayesian Monte Carlo Markov Chain (MCMC) simulations
with the selected evolution models as partitioned models and
relaxed molecular clock were generated by BEAST (Drummond
and Rambaut, 2007) and used to estimate the evolutionary
parameters of each serotype. A Bayesian skyline plot was utilized
as a coalescent prior as described in previous publications (Ong
et al., 2008; Schreiber et al., 2009). For each type of dengue virus,
we conducted a run of 100,000,000 replications with sampling of
every 1000th, resulting in 100,000 chains. MCC (Maximum Clade
Credibility) phylogenetics trees and evolutionary parameters were
summarized with 25% burn-in. Tree visualization and sample
labeling was performed using FigTree software (http://tree.bio.ed.
ac.uk/software/ﬁgtree).
2.5. Viral growth kinetic assay
Vero76 cells were seeded at a density of 2  105 cells and
allowed to attach overnight in 24 well plates (Nunc). Cells were
then infected with viruses in duplicate using a multiplicity of infec-
tion (moi) of 0.1 in 1 MEM supplemented with 2% FBS and incu-
bated at 37 C, 5% CO2 for 1 h. Three to ﬁve different virus isolates
for each serotype were assayed. For comparison between
Genotypes of DENV-1, four different isolates were used for eachgenotype. Inoculation media were aspirated and replenished with
fresh medium following incubation. Culture supernatants were
collected at 12 h intervals (i.e., 12, 24, 36, 48, 60, and 72 h post
inoculation) and stored directly in 80 C freezer. Viral titers from
each time point were quantiﬁed using a standard plaque assay on
BHK-21 cell lines as described previously (Fink et al., 2007) and
plotted as kinetic curves showing the mean titer and standard
deviation. Statistical analysis was done using SPSS Statistics soft-
ware version 17.0 (SPSS Inc., Chicago, IL). One-way analysis of vari-
ance (ANOVA) was used to analyze and compare means of viral
titer among DENV serotypes. Comparison of viral growth kinetic
between two genotypes of DENV-1 was done using independent-
samples Student’s t-test. A probability value of p < 0.05 was consid-
ered statistically signiﬁcant.
3. Results
3.1. Dengue incidence in Makassar city
Four hundred and ﬁfty-ﬁve febrile patients were recruited dur-
ing May 2007–August 2010. Of these, 197 (43.3%) patients were
conﬁrmed dengue as determined by NS1 rapid test kit. RT-PCR
detections were performed on NS1-positive samples and a total
of 126 sera (27.7% of all dengue-suspected patients) were detected
as dengue positive. The male to female ratio was 1.14, with an
average age of 12.5 ± 10.2 years old. Cases occurred predominantly
in those aged between 11 and 20 years old (40%). Most dengue
positive cases (n = 165 or 83.8%) were secondary infections, as
determined by IgM and IgG ELISA ratio.
3.2. Dengue virus serotype distribution
We performed serotyping on RT-PCR-conﬁrmed dengue cases
using a standard RT-PCR serotyping method (Lanciotti et al.,
1992) and obtained results in 126 cases, that demonstrated the cir-
culation of all four dengue serotypes in Makassar. The predominant
serotype was DENV-1 with 51 isolates (41%), followed by DENV-2
with 39 isolates (31%). Twenty-ﬁve isolates (20%) were DENV-3;
and the remaining nine isolates (7%) were DENV-4. Two samples
were mixed-infection of DENV-1 and -2 and DENV-2 and -3. We
compared previous publications on serotype distributions in other
parts on Indonesia (Corwin et al., 2001; Graham et al., 1999; Porter
et al., 2005; Sukri et al., 2003; Suwandono et al., 2006; Yamanaka
et al., 2011) with our results. We observed a distinct serotype dis-
tribution of DENV in Makassar compared to other cities throughout
the Indonesian archipelago although we cannot be certain that
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those cities.
3.3. Phylogenetic analysis of dengue viruses
To determine the predominant genotypes in Makassar, we per-
formed full-length genome sequencing of the isolated viruses.
Virus genomic RNAs were extracted either from patient sera or
after one passage of virus propagation in tissue culture. We
obtained the complete genome sequences of 80 viruses covering
all four serotypes. Table 1 describes the characteristics of the
sequenced isolates including the length of the sequenced genomes.
Using a fast maximum-likelihood method as implemented in
FastTree, we performed an approximate phylogenetic analysis of
all dengue serotypes to select 60 most-closely related sequences
of each dengue sample for reference sequences for consecutive
analysis.
The MCC (Maximum Clade Credibility) phylogenetic tree of
DENV-1 isolates and their closest reference sequences was shown
in Fig. 1. Based on the DENV-1 genotype classiﬁcation by
Goncalvez et al. (2002), we observed the circulation of two geno-
types of DENV-1 in Makassar. The majority of the viruses, including
all recent 2010 samples (29 isolates) belong to Genotype I. The 28
isolates of Genotype I were from single ancestor and had the time
to the most recent common ancestor (TMRCA) around 2005. One of
the recent samples (WS88) probably followed an independent
route of introduction as it had similar lineage with samples from
Singapore. All of Genotype I samples were clustered together with
viruses from China, Thailand, and Singapore, including the
Singapore dengue outbreak isolates of 2005. The rest of the
Makassar’s DENV-1 viruses (6 isolates) were grouped into
Genotype IV. Three of the isolates were clustered together with
samples from Brunei (in 2006), Hawaii (in 2001), Philippines (in
2004) and China (in 1991), and their ancestor was likely to be
the same as the West Paciﬁc sample of 1974 isolate. The other
three isolates were clustered with China isolates of 2002/2003
and Indonesian city of Palembang in 1998. It should be noted that
DENV-1 isolates from other Indonesian region were not included in
the analysis as they are more likely to distantly related to Makassar
samples and were not selected during the FastTree/patristic dis-
tance ﬁltering process. This observation contributes to new infor-
mation on the DENV-1 genotype distribution in Indonesia.
We determined 26 DENV-2 genome sequences from Makassar
isolates and constructed an MCC phylogenetic analysis of those
viruses together with previously published DENV-2 genomes.
Based on the DENV-2 genotype classiﬁcation reported by Twiddy
et al. (2002), all of our Makassar isolates were grouped into the
Cosmopolitan genotype (Fig. 2). This genotype is widely dissemi-
nated from India to South East Asia, Africa, the Middle East, and
Australia. Within the Cosmopolitan genotype, the Makassar iso-
lates grouped together with two isolates from Jakarta in 2004
and many isolates from Singapore (in 2004, 2005 and 2008). The
phylogenetic trees suggested the presence of spatial isolation
among DENV-2 strains from cities in the western and eastern parts
of Indonesia, but the absence of spatial isolation between Makassar
and Singapore. The tree also indicated that DENV-2 viruses cur-
rently circulating in Makassar were of multiple entries.
Phylogenetic analysis of 13 DENV-3 genome sequences from
Makassar identiﬁed them as belonging to Genotype I, based on
the classiﬁcation described by Lanciotti et al. (1994). This genotype
consists of viruses from Indonesia, Malaysia, the Philippines and
the South Paciﬁc islands (Lanciotti et al., 1994). Indonesian viruses
collected in 1973, 1978 and 1985 also grouped into this genotype
(Lanciotti et al., 1994), as did recent isolates from Jakarta in 2004
and Palembang in 1998 (Ong et al., 2008), as shown in Fig. 3.
Nine Makassar isolates were clustered with Indonesian isolates of1998 and 1988 from Jakarta and were from single common ances-
tor with TMRCA of 1990. Four other Makassar isolates, including
the recent 2010 samples, were clustered with the rest of
Indonesian isolates from 1998 and 2004, as well as from Timor
Leste in 2005 and 2005/2009 from Singapore. This may indicate
that all the Makassar samples were originated from and spread
in Indonesia and neighboring countries such as Singapore and
Timor Leste. TMRCA of all Makassar isolates together with other
Indonesian isolates was 1965. Together this suggests the presence
of strong temporal structure and that the Makassar’s DENV-3
viruses appeared to be part of an older lineage which was indeed
endemic in the Indonesian region and had been circulating for
more than four decades.
We performed phylogenetic analysis on the genomes of 6
DENV-4 viruses isolated from Makassar and compared them with
available DENV-4 genomes in the GenBank. As shown in Fig. 4,
the Makassar isolates fell into Genotype II based on Lanciotti clas-
siﬁcation (Lanciotti et al., 1997). This genotype is commonly found
in South-east Asia and America (Lanciotti et al., 1997). The
Makassar isolates grouped closely with other Indonesian isolates
from Jakarta that were isolated in 2004. Four of the Makassar sam-
ples in the same lineage with the Jakarta samples were originated
from a lineage which has higher mutation rate relative to other
samples. The TMRCA of these 4 Makassar samples and the related
Jakarta samples was around year 1990. This clustering suggests the
endemicity of this DENV-4 genotype in Indonesia, and the presence
of strong temporal link among DENV-4 viruses in Indonesia.
3.4. Evolutionary dynamics and amino acid comparison of Makassar
dengue viruses
The estimated evolutionary rates for substitution dynamics of
all serotypes, as calculated by BEAST, were 1.1  103 sub-
stitution/site/year (95% highest probability density (HPD),
0.6  103–1.8  103 substitution/site/year) and 1.5  103 sub-
stitution/site/year (95% HPD, 0.7  103–1.7  103 substitution/
site/year) for DENV-1 and DENV-2, respectively. Similar estimates,
1.1  103 substitution/site/year (95% HPD, 6.2  104–
1.5  103 substitution/site/year) and 0.2  103 substitution/
site/year (95% HPD, 1.5  104–0.8  103 substitution/site/year),
were observed for DENV-3 and DENV-4, respectively.
The estimated ages of the most recent common ancestors
(TMRCA) for all serotypes were 62 months (95% HPD, 53–
91 months), 58 months (95% HPD, 51–86 months), 56 months
(95%HPD, 49–82 months) and55 months (95%HPD, 45–78 months)
for DENV-1, DENV-2, DENV-3 and DENV-4, respectively.
A relatively low ratio of non-synonymous to synonymous sub-
stitution per site (dN/dS) in all genes indicated that there was no
evidence for positive selection in any gene and no evidence for
site-speciﬁc positive selection of the Makassar viruses (Table 2).
Several genes had ratio of 1.0 for dN/dS in DENV-4, however due
to small number of DENV-4 isolates, we feel that the dN/dS for
DENV-4 cannot be determined conﬁdently.
Comparative analysis at the amino acid levels were illustrated
in Fig. 5 for DENV-1 Genotype I (A), DENV-1 Genotype IV (B),
DENV-2 (C), DENV-3 (D) and DENV-4 (E). Although DENV-1
Genotype I had the most sample number, the differences were
the smallest among the sample set, and substantially much smaller
than the DENV-1 genotype IV. In DENV-1 Genotype I residue 123 of
E gene was observed to be either Serine (S) or Threonin (T) in many
2007 samples, but only observed to be T in all 2008 samples.
Likewise, residue 222 of NS1 gene in some 2007 samples were
observed to be S or T, while the rest of 2008 samples were
observed to be T. However, residue 829 of NS5 gene which were
observed to be Isoleucine (I) for all 2007 samples, started to have
Valine (V) in some of 2008 samples. The rest of changes in the
Fig. 1. MCC (Maximum Clade Credibility) phylogenetic tree of DENV-1 Genotype I and Genotype IV. The tree consisted of 35 complete genomes of DENV-1 viruses isolated
from Makassar, Indonesia together with their close-distanced genomes available in the GenBank database and was constructed using Bayesian inference as implemented in
BEAST. All Makassar isolates were denoted with red labels, while samples from Indonesian cities of Palembang and Jakarta were denoted with green labels. Posterior
probabilities of all major branches had values of more than 0.75, indicating the signiﬁcant of the tree topology. The red line for a branch indicated that the rate of mutation of
that particular branch was relatively faster compared to the overall rate of mutation, while the blue line indicated slower rate of mutation. The MCC tree branched into 2 main
branches, the genotype IV (upper branch) and I (lower branch). Six of the Makassar isolates grouped into genotype IV, while the rest of Makassar isolates grouped into
genotype I. Labels indicating the origin of isolates are as follow: BN (Brunei), CL (Chile), CN (China), ID (Indonesia), JP (Japan), MY (Malaysia), NR (Nauru Island), PF (Polynesian
French), PH (Philippines), RE (Reunion Island), SG (Singapore), SC (Seychelles Island), TH (Thailand), and US (United States). Dots in the nodes represent the posterior
probability, with large blue dots, medium purple dots and small red dots indicate posterior probability >0.75, 0.75–0.5, and <0.5, respectively.
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Fig. 2. MCC phylogenetic tree of DENV-2 genotype Cosmopolitan. The tree consisted of 26 complete genomes of DENV-2 viruses isolated from Makassar, Indonesia, together
with their close-distanced genomes available in the GenBank database and was constructed using Bayesian inference as implemented in BEAST. All Makassar isolates were
denoted with red labels, while samples from Indonesian cities of Palembang and Jakarta were denoted with green labels. Posterior probabilities of all major branches had
values of more than 0.75, indicating the signiﬁcant of the tree topology. The red line for a branch indicated that the rate of mutation of that particular branch was relatively
faster compared to the overall rate of mutation, while the blue line indicated slower rate of mutation. Labels indicating the origin of isolates are as follow: AU (Australia), BN
(Brunei), CN (China), GU (Guam), ID (Indonesia), SG (Singapore), TW (Taiwan) and VN (Vietnam). Dots in the nodes represent the posterior probability, with large blue dots,
medium purple dots and small red dots indicate posterior probability > 0.75, 0.75–0.5, and < 0.5, respectively.
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Fig. 3. MCC phylogenetic tree of DENV-3 Genotype I. The tree consisted of 13 complete genomes of DENV-3 viruses isolated from Makassar, Indonesia, together with their
close-distanced genomes available in the GenBank database and was constructed using Bayesian inference as implemented in BEAST. All Makassar isolates were denoted with
red labels, while samples from other Indonesian regions were denoted with green labels. Magenta labels indicated Indonesian wild-type samples that have undergone serial
passages in Vero cells. Posterior probabilities of all major branches had values of more than 0.75, indicating the signiﬁcant of the tree topology. The red line for a branch
indicated that the rate of mutation of that particular branch was relatively faster compared to the overall rate of mutation, while the blue line indicated slower rate of
mutation. Labels indicating the origin of isolates are as follow: BR (Brazil), CK (Cook Islands), CN (China), ID (Indonesia), LK (Sri Lanka), MZ (Mozambique), PF (Polynesian
French), PH (Philippines), SG (Singapore), TH (Thailand), TL (East Timor), TW (Taiwan), and WS (Western Samoa). Dots in the nodes represent the posterior probability, with
large blue dots, medium purple dots and small red dots indicate posterior probability > 0.75, 0.75–0.5, and < 0.5, respectively.
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signiﬁcant.
In DENV-1 Genotype IV, the most diverse samples, we
observed more signiﬁcant differences in the amino acid changes.
Some sites, notably residue 217 of E, 115 of NS2B, 119 of NS3,
426 of NS3, 123 of NS4A genes, contained amino acid Proline
(P) which structurally different than that of other amino acids
as it had cyclic group in its backbone chain, which might bend
the backbone slightly (Fig. 5B).In DENV-2, similar differences also occurred in the amino acid
changes. Residue 217, 332 and 384 of E, 320 of NS1, and 837 of
NS5 contained a mix of amino acid Proline (P) and Leucine (L).
Changes that were likely to be signiﬁcant occurred in M (residue
57 and 71), E (residue 346), and NS5 (residue 563 and 570) as they
involved changes of amino acids with different physicochemical
properties (Fig. 5C).
Both DENV-3 and DENV-4 comparative analysis showed that
most differences came from 1 or 2 amino acid changes in most of
Fig. 4. MCC phylogenetic tree of DENV-4 Genotype II. The tree consisted of 6 complete genomes of DENV-4 viruses isolated from Makassar, Indonesia, together with their
close-distanced genomes available in the GenBank database and was constructed using Bayesian inference as implemented in BEAST. All Makassar isolates were denoted with
red labels, while samples from other Indonesian regions were denoted with green labels. Posterior probabilities of all major branches had values of more than 0.75, indicating
the signiﬁcant of the tree topology. The red line for a branch indicated that the rate of mutation of that particular branch was relatively faster compared to the overall rate of
mutation, while the blue line indicated slower rate of mutation. Labels indicating the origin of isolates are as follow: BR (Brazil), CO (Colombia), CN (China), DM (Dominica), ID
(Indonesia), HT (Haiti), PF (Polynesian French), PH (Philippines), PR (Puerto Rico), SG (Singapore), TH (Thailand), TW (Taiwan), US (United States), and VE (Venezuela). Dots in
the nodes represent the posterior probability, with large blue dots, medium purple dots and small red dots indicate posterior probability >0.75, 0.75–0.5, and <0.5,
respectively.
Table 2
Evolutionary patterns among the proteins of DENV-1, -2, -3 and -4 sampled from Makassar, Indonesia during 2007–2010.
Protein Length (bp) DENV-1 DENV-2 DENV-3 DENV-4
IS dN/dS IS dN/dS IS dN/dS IS dN/dS
Capsid (C) 342 24 0.25 12 0.17 1 0 1 1.0
Membrane (M) 498 52 0.13 19 0.11 2 0.5 0 0
Envelope (E) 1479 167 0.11 53 0.10 11 0.1 0 0
NS1 1056 102 0.18 40 0.17 5 0.2 1 1.0
NS2A 654 75 0.19 27 0.19 7 0.29 3 0
NS2B 390 36 0.19 13 0.08 3 0 3 0.67
NS3 1857 187 0.11 67 0.03 15 0.2 2 1.0
NS4A 450 49 0.10 14 0 0 0 0 0
2K 68 8 0 4 0 0 0 1 0
NS4B 744 73 0.04 27 0.07 4 0 2 0.5
NS5 2679 230 0.10 103 0.18 10 0 8 0
Genome* 10170 1003 NA 379 NA 58 NA 21 NA
* Coding region only; IS, number of informative sites; NA, not applicable.
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DENV-4 are too small to conﬁdently detect any signiﬁcant changes
or evidence of positive selection within these clades (Fig. 5D
and E).3.5. Growth characteristics of Makassar DENV
Our study observed the circulation of all four DENV serotypes in
Makassar. Phylogenetic analyses revealed the genotypes of viruses
Fig. 5. Comparative analyses of amino acid substitutions among Makassar’s DENV-1 viruses genotype I (A) and IV (B), DENV-2 viruses (C), DENV-3 viruses (D), and DENV-4
(E). Genes in which the substitutions present are shown above the amino-acid numbers. Amino acid coloring scheme is according to AESNN3 (Lin et al., 2002).
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several clades within each genotype (Figs. 1–4). It has been sug-
gested that particular genotypes of DENV possess different rates
of transmission and that some genotypes have a tendency to cause
more severe forms of dengue disease and are thus more virulentthan others (Rico-Hesse, 2010). One way to estimate the virulence
is by assessing the replication kinetics of the virus (Rico-Hesse,
2010).
To determine the growth characteristics of Makassar’s DENV,
we measured the replication kinetics of all four serotypes and
Fig. 6. Replication kinetic assays of selected DENV from Makassar. (A) Replication kinetic comparison of four DENV serotypes. (B) Replication kinetic comparison of DENV-1
Genotype I and Genotype IV strains. Data were the mean ± SD of three to ﬁve virus isolates representing each serotype/genotype performed in duplicate.
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four viruses representing each serotype/genotype were assayed for
their replication kinetics. Growth kinetic comparison of DENV-1,
-2, -3, and -4 is shown in Fig. 6. We observed serotype-speciﬁc
differences in replication at 36 and 48 h post-infection, with
DENV-1 and -2 replicating to higher levels compared with
DENV-3 and -4 (Fig. 6A).
Next, we compared the replication kinetics of viruses belong to
two different genotypes of DENV-1, i.e., Genotype I and IV (Fig. 6B).
Genotype I apparently replicated at higher level compared to
Genotype IV (p value < 0.05). This suggests the relatively better ﬁt-
ness of Genotype I which may underlie the ability of this Genotype
to replace the Genotype IV in the community. Similar kinetic pat-
terns were observed when other cell line (C6/36) was used in
growth kinetic experiment (data not shown). Replication kinetic
assays on four viruses representing four clades of DENV-2 did
not show any signiﬁcant difference (data not shown).4. Discussion
We conducted the ﬁrst molecular-typing study of dengue in
Makassar-Indonesia to investigate dengue disease dynamics in
the area from 2007 to 2010. As conﬁrmed by NS1 antigen detec-
tion, we observed dengue viruses infected a remarkable 43.3% of
febrile patients presenting to hospital. This data reﬂects theimportance of the disease in Makassar and the considerable burden
it must place on the local economy and health infrastructure. In
terms of infection status, based on IgM and IgG ELISA detection,
our data showed a high number of secondary dengue infections
in hospitalized patients who participated in this study (83.8%),
indicating a sustained disease intensity over a number of years.
The age distribution of the hospitalized patients was found to be
highest in young patients (10–20 years old), similar to other parts
of Indonesia (Corwin et al., 2001). It is likely that this predominant
age group may correlate with the higher proportion of secondary
infections observed.
To date, no serotype distribution data has been available for
Makassar. Our study demonstrated the circulation of all four den-
gue serotypes. We observed the predominance of DENV-1 (41%)
followed by DENV-2, -3, -4. This distribution is distinct from his-
torical reports in other parts of Indonesia, especially in the
Western regions of the archipelago, e.g., in the cities of Jakarta
and Palembang in 2004, in which DENV-3 was the predominant
serotype in the area and correlated with severe symptoms. It
would be interesting to know if the current serotype distributions
in Jakarta and Palembang match their historical values or if they
are now closer to what we have found in Makassar.
To study the evolutionary dynamics and phylogeny of
Makassar’s dengue viruses, we performed whole-genome sequenc-
ing of 80 virus isolates. Most of the genomes were sequenced from
primary infection samples due to difﬁculties in virus isolation from
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2011). Based on the published classiﬁcation of dengue virus’s geno-
types, we identiﬁed the co-circulation of Genotypes I and IV of the
DENV-1 serotype. The nearest geographical areas that have been
reported as harboring Genotype I are Singapore (Schreiber et al.,
2009), Thailand (Ong et al., 2008) and Surabaya (Yamanaka et al.,
2011). The clustering of all Genotype I samples together with
viruses from China, Thailand, and Singapore may suggest that the
Genotype I isolates were originated from China, migrated to
Thailand and passed Singapore before entering Makassar (Fig. 1).
Genotype IV was predominant in Jakarta in 2004 (Schreiber
et al., 2009) and was also present in Makassar in smaller numbers.
The close genetic relationship between the Makassar and
Singapore Genotype I isolates suggests a recent importation has
occurred and that the incumbent clade is being replaced. While
the Genotype IV strains from Makassar are quite diverse the
Genotype I strains appear to be relatively uniform further suggest-
ing a recent introduction. We will continue to survey viruses from
the region to see if Genotype I succeed in displacing Genotype IV.
Makassar’s DENV-2 viruses grouped into the Cosmopolitan
genotype. This genotype circulates widely in India, South East
Asia, Africa, the Middle East, and Australia (Twiddy et al., 2002).
This genotype was also circulating in the cities of Jakarta in 2004
and Palembang in 1998. Phylogenetic analysis showed that closely
related Cosmopolitan genotype strains were isolated in Jakarta in
2004, Brunei and Singapore in 2005, Vietnam in 2006 and
Makassar in 2007 and 2008. It appears that the Cosmopolitan
genotype is very successful in spreading, regionally endemic and
continually re-distributing in South East Asia. The phylogenetic
trees suggested the presence of spatial isolation among DENV-2
strains from cities in the western and eastern parts of Indonesia,
but the absence of spatial isolation between Makassar and
Singapore (Fig. 2). The tree also indicated that DENV-2 viruses cur-
rently circulating in Makassar were of multiple entries.
Presumably, frequent direct air and sea travel between Makassar
and Singapore is rapidly distributing the viruses between the two
cities. Another explanation of the possible spatial isolation among
Indonesian cities is that there is no other whole genome sequence
data that has been reported and submitted to GenBank.
Our phylogenetic analysis revealed that Makassar’s DENV-3
viruses grouped into Genotype I, similar to isolates from Jakarta
in 2004 and Palembang in 1998, and same genotype as
Indonesian strains from 1978, 1988, 1996 and 1998 isolates. This
genotype has been described as causing four epidemics in the
region in the past (Ong et al., 2008), and is most likely a local,
Indonesian endemic strain that has circulated for more than three
decades. It is interesting that the isolates we found in Makassar
appear to be more closely related to strains from 1996 and 1998
than the strains more recently found in Timor-Leste, Jakarta,
Singapore and Palembang suggesting DENV-3 in Makassar has
been following a separate evolutionary history since 1988.
The DENV-4 viruses we isolated clustered into Genotype II (SE
Asia and America), the same genotype as those isolated in Jakarta
in 2004. Four of the Makassar samples were originated from a lin-
eage with higher mutation rates relative to other samples, and
were direct descendant from ancestor of those Jakarta samples
with TMRCA around year 1990. Higher mutation rates might indi-
cate that this particular lineage was spreading rather quickly, as in
outbreak cases. As such, those particular Makassar isolates were
assumed to be descendant of Jakarta outbreak in 1998. Partial
sequences of viruses from 1973, 1976, 1977 isolates also cluster
into this clade (not shown). This genotype appears to be endemic
in Indonesia and has been circulating for over 30 years.
A Bayesian coalescent approach was used to infer the evolution-
ary dynamics for all serotypes of isolates within 2007–2010 in
Makassar (Drummond and Rambaut, 2007). We observed the meanof evolution rates for DENV-1, DENV-2 and DENV-3 were similar
and roughly equivalent to those estimated previously for all
DENV serotypes (Twiddy et al., 2003). The mean age of the com-
mon ancestor for DENV-1, DENV-2 and DENV-3 indicated that each
of these diverse lineages had common ancestors already present in
Makassar since approximately 2003. Since the number of samples
for DENV-4 was small, we could not conﬁdently estimate the mean
age of the common ancestor of these isolates. That we did not see
any convincing evidence for positive selection in any of the sero-
types indicates that these strains are already well adapted to their
environment.
The analysis based on the amino acid sequences of the
Indonesian samples showed that some positions were under-
going amino acid substitutions from 2007 to 2008. That we did
not see any convincing evidence for positive selection in any of
the serotypes indicates that these strains are already well
adapted to their environment, and that the amino acid sub-
stitutions might not have affected the characteristics of viruses
substantially.
Genetic variations in dengue viruses have been described as
being risk factors for severe disease (Balmaseda et al., 2006;
Messer et al., 2003; Rico-Hesse et al., 1997) and particular sero-
types/genotypes are suggested to have a tendency to cause more
severe forms of dengue (i.e., DHF and DSS) and larger outbreaks.
For example, DENV-2 and DENV-3 have been associated with sev-
ere disease and DENV-4 is claimed to lead to a milder illness
(Nisalak et al., 2003; Vaughn et al., 2000). One of the ways to esti-
mate the virulence or ﬁtness of a virus in vitro is by looking at the
virus replication rate (Rico-Hesse, 2010). In this study, we com-
pared the replication kinetics of various serotype/genotypes of
DENV to determine whether particular serotype/genotypes repli-
cate better than others do.
The co-circulation of two DENV-1 genotypes (i.e., Genotype I
and IV) prompted us to compare their replication rates. Isolates
grouped into Genotype I apparently replicated at higher level com-
pared to Genotype IV. This suggests the relatively better ﬁtness of
Genotype I which may underlie the ability of this genotype to
replace the Genotype IV in the community. Thus, this observation
suggests that different genotypes of DENV may exhibit different
phenotypic characteristics, as in the case of American and South
East Asian genotypes of DENV-2 (Leitmeyer et al., 1999; Rico-
Hesse et al., 1997). Continuous surveillance is currently underway
to conﬁrm the predominant circulation of Genotype I.
The DENV-2 American and South East Asian genotypes are
known to have differences in their replication ability. American
genotypes replicated less well than the South East Asian viruses
in in vitro experiments (Pryor et al., 2001). As all of our DENV-2
viruses were grouped into Cosmopolitan genotype (Fig. 3), we
could not perform replication comparisons against other geno-
types. However, within the Cosmopolitan genotype, we observed
the grouping of viruses into clades. To determine whether there
are differences in growth, four viruses representing each clade
were assayed for their replication kinetics. We observed no signiﬁ-
cant differences among those four viruses (data not shown), sug-
gesting that members of the genotype are quite homogenous in
their growth rates. Similar observation is also present in DENV-3
and -4 (data not shown). A typical DENV growth kinetic proﬁle
was also observed in other virus isolates from other cities in
Indonesia (data not shown).
In summary, we have revealed the dengue serotype and geno-
type distribution in Makassar and observed that although these
viruses have very similar evolutionary dynamics they have
remarkably different phylogeographic histories. We observed the
different replication rates of DENV-1 Genotype I and Genotype
IV, which may underlie the ability of Genotype I in replacing the
Genotype IV in Makassar, Indonesia.
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